Sponsor or institution
Clinical trials and research at Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives that are recruiting, in France. By phase: Phase 4 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Characterization of Colorectal Dysplastic Lesions and Changes in Risk in IBD Patients | — | Amiens and 1 other locations | Recruiting | Jul 22, 2026 |
| Guselkumab in Crohn's Disease: Optimising Care for Real-World Patients (OPTIM Study A) | Phase 4 | Amiens | Recruiting | Jun 1, 2026 |
| Mirikizumab for Crohn's Disease: See if it helps heal the bowel walls | Phase 4 | Brest and 7 other locations | Recruiting | Dec 18, 2025 |
| Observational study on safety concerns in IBD patients treated with specific therapies in France | — | Amiens and 1 other locations | Recruiting | Oct 18, 2023 |
| Comparing standard care with targeted treatment and monitoring for ulcerative colitis patients starting adalimumab | Phase 4 | Cholet, Maine Et Loire and 23 other locations | Recruiting | Dec 3, 2019 |
All recruiting trials (5)
-
Characterization of Colorectal Dysplastic Lesions and Changes in Risk in IBD Patients
This study tests how colorectal dysplastic lesions in adults with Crohn disease or ulcerative colitis change over time to help tailor screening and treatment.
-
Guselkumab in Crohn's Disease: Optimising Care for Real-World Patients (OPTIM Study A)
This study tests whether guselkumab can help adults with Crohn's disease, including those who have had prior therapies or partial responses, when used in real-world clinical settings.
-
Mirikizumab for Crohn's Disease: See if it helps heal the bowel walls
This trial tests whether mirikizumab can help patients with Crohn's disease achieve transmural healing.
-
Observational study on safety concerns in IBD patients treated with specific therapies in France
This study is trying to see if certain treatments for Crohn's disease and ulcerative colitis are safe and if they affect patients' health and costs over time.
-
Comparing standard care with targeted treatment and monitoring for ulcerative colitis patients starting adalimumab
This study is testing if a new approach that includes extra monitoring and education can help adults with moderate to severe ulcerative colitis feel better when they start treatment with adalimumab, compared to standard care.
Quick answers
How many clinical trials run by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in France. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.